Thanks for this. I was a bit perplexed at first glance at the data. I made a short note of it in a reply in someone's note. Thanks for fleshing it out more. The one thing that struck me was the age ranging from 18-87 with just 5% over 65 and a median of 42. Symptoms alleviation in 12 vs 13 days means that we are talking about the second of the bi-phasic, the cytokine inflammatory, phase. Not the viral replication phase. Imagine my naive thinking that reducing hospitalization, ICU and death was the goal.
Thanks for this. I was a bit perplexed at first glance at the data. I made a short note of it in a reply in someone's note. Thanks for fleshing it out more. The one thing that struck me was the age ranging from 18-87 with just 5% over 65 and a median of 42. Symptoms alleviation in 12 vs 13 days means that we are talking about the second of the bi-phasic, the cytokine inflammatory, phase. Not the viral replication phase. Imagine my naive thinking that reducing hospitalization, ICU and death was the goal.